Novasys Medical
Jump to navigation
Jump to search
Novasys Medical "is dedicated to the development of innovative therapies in women's health. The company has recently launched its first product: the Renessa® System, a proprietary, non-surgical treatment for female stress urinary incontinence (SUI)" [1]
- Debra Reisenthel - President and Chief Executive Officer
- Charles Carignan, M.D. - Executive Vice President and Chief Medical Officer
Contents
Directors
Accessed August 2008: [2]
- David Douglass (Delphi Ventures)
- Douglas Kelly, MD (Alloy Ventures)
- Ray Larkin, Jr., Chairman (Industry Representative)
- Richard Lin ((Three Arch Partners)
- Debra Reisenthel (President and CEO, Novasys Medical, Inc.)
- Beckie Robertson (Versant Ventures)
- Steve Sullivan, MD (Skyline Ventures)
Additional Key Investors
Accessed August 2008: [3]
- Affinity Capital Management
- GBS Venture Partners
- Hercules Technology Growth Capital, Inc.
- INVESCO Private Capital
- JPMorgan Partners (managed by Panorama Capital)
- NSET Ventures
Contact
Resources and articles
Related Sourcewatch articles
References
- ↑ Home, Novasys Medical, accessed August 31, 2008.
- ↑ Leadership, Novasys Medical, accessed August 31, 2008.
- ↑ Leadership, Novasys Medical, accessed August 31, 2008.
